OverviewChartNewsTraderScreen

BVT Knock-Out PGR/  DE000VC2PUM7  /

EUWAX
8/23/2024  9:47:55 PM Chg.- Bid10:00:33 PM Ask10:00:33 PM Underlying Strike price Expiration date Option type
0.001EUR - -
Bid Size: -		 -
Ask Size: -		 Progressive Corporat... 238.62 - 12/31/2078 Put
GlobeNewswire 8/19 Emergent BioSolutions Responds to Mpox Public Health Emergency as Cases Surge in Africa
GlobeNewswire 8/19 Tiziana Life Sciences Appoints New Chief Executive Officer
GlobeNewswire 8/19 Fulcrum Therapeutics Strengthens Leadership Team with the Appointments of Isabel Kalofonos as Chief ...
GlobeNewswire 8/19 CN Issues Lockout Notice to Teamsters
GlobeNewswire 8/15 Abata Therapeutics Announces Strategic Investment from Bristol Myers Squibb Supporting Advancement o...
GlobeNewswire 8/14 Progressive Reports July 2024 Results
GlobeNewswire 8/14 Atsena Therapeutics Receives Rare Pediatric Disease Designation from the U.S. FDA for ATSN-201 Gene ...
GlobeNewswire 8/14 Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule
GlobeNewswire 8/13 Eyenovia to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
GlobeNewswire 8/12 Eyenovia Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Newsfile Corp 8/12 The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors
TeleTrader 8/11 Bank of Russia says rates could reach 20%
GlobeNewswire 8/8 Opthea to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference, August 15,...
GlobeNewswire 8/8 Eyenovia to Report Second Quarter 2024 Results on Monday, August 12th
GlobeNewswire 8/7 Eyenovia and Formosa Pharmaceuticals Initiate Co-Development of Clobetasol Propionate Ophthalmic Sus...
GlobeNewswire 8/7 AGS Unveils its Latest Table Innovation Bonus Spin Xtreme for Poker Rooms and an Exciting New Lineup...
GlobeNewswire 8/7 Team, Inc. Announces Timing of Second Quarter Earnings Release and Conference Call
TeleTrader 8/7 Cori Bush loses Missouri Democratic primary
GlobeNewswire 8/6 TG Therapeutics Reports Second Quarter 2024 Financial Results and Raises BRIUMVI® (ublituximab-xiiy)...
GlobeNewswire 8/6 Levicept Announces Positive Results of Phase II Trial of novel Neurotrophin-3 Inhibitor, LEVI-04, fo...
TeleTrader 8/6 Aramco's Q2 net income down 3.2% to $29.1 billion
GlobeNewswire 8/5 Progressive Announces Quarterly Common Share Dividend
GlobeNewswire 8/5 NeOnc Technologies Begins Enrollment for Phase 2 Clinical Trial of NEO100-02™ for Patients Afflicted...
GlobeNewswire 8/5 Annexon Provides Update on ARCHER II Global Registrational Program in Geographic Atrophy
GlobeNewswire 7/30 Progressive Announces Investor Relations Event